MRI Contrast Agents Linked to Skin Disorder
The FDA has recently updated an earlier Public Health Advisory concerning gadonium-based contrast agents, which are drugs injected into patients in Magnetic Resonance Imaging (MRI)
and Magnetic Resonance Angiography (MRA) procedures.
read more |